Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Sloan Kettering Inst Can Research
New York, New York
The records below are financial disclosure and conflict of interest records obtained by ProPublica from the National Institutes of Health and dozens of large public universities across the country. The NIH only has records for researchers who seek or receive its funding.
Total Disclosures: 92
| Name | Type | Company | Disclosed Value | Year Filed |
|---|---|---|---|---|
| Ulrich Wiesner | Conflict of Interest | Claymore Technologies, Inc. | 2016 | |
| Robert Jenq | Conflict of Interest | Seres Therapeutics | 2016 | |
| Jan Grimm | Conflict of Interest | Nortis Bio | 2017 | |
| Gavril Pasternak | Conflict of Interest | Sparian Biosciences | 2019 | |
| Milind Rajadhyaksha | Conflict of Interest | Caliber ID | 2018 | |
| Milind Rajadhyaksha | Conflict of Interest | Caliber ID | 2018 | |
| Marcel van Den Brink | Conflict of Interest | Seres Therapeutics | 2018 | |
| Steven Larson | Conflict of Interest | Claymore Nanotechnologies LLC | 2013 | |
| Michelle Bradbury | Conflict of Interest | Claymore Nanotechnologies LLC | 2013 | |
| Laurence Rahme | Conflict of Interest | Spero Therapeutics, Inc. | 2014 | |
| Robert Jenq | Conflict of Interest | Epiva Therapeutics | 2015 | |
| Jan Jensen | Conflict of Interest | Trailhead Biosystems, Inc. | 2015 | |
| Richard Kolesnick | Conflict of Interest | Cermamedix | 2019 | |
| Alan Hanash | Conflict of Interest | Ceramedix | 2018 | |
| Renier Brentjens | Conflict of Interest | Juno Therapeutics | 2016 | |
| Tao Dao | Conflict of Interest | Eureka Therapeutics | 2018 | |
| Tao Dao | Conflict of Interest | Eureka Therapeutics | 2018 | |
| Daniel Heller | Conflict of Interest | Goldilocks Therapeutics | 2018 | |
| Ryan Williams | Conflict of Interest | Goldilocks Therapeutics | 2018 | |
| Renier Brentjens | Conflict of Interest | Juno Therapeutics | 2018 | |
| Andrew Vickers | Conflict of Interest | OPKO Health | 2018 | |
| Charles Sawyers | Conflict of Interest | ORIC Pharmaceuticals | 2018 | |
| Hans Lilja | Conflict of Interest | OPKO Health | 2017 | |
| Michelle Bradbury | Conflict of Interest | Elucida Oncology, Inc. | 2017 | |
| Andrew Vickers | Conflict of Interest | OPKO Health | 2017 | |
| David Scheinberg | Conflict of Interest | Sellas Life Sciences Group | 2018 | |
| Jan Grimm | Conflict of Interest | Nortis Bio | 2017 | |
| Susanne Kossatz | Conflict of Interest | Summit Biomedical Imaging, LLC | 2018 | |
| Thomas Reiner | Conflict of Interest | Summit Biomedical Imaging, LLC | 2018 | |
| Snehal Patel | Conflict of Interest | Summit Biomedical Imaging, LLC | 2018 | |
| Gabriela Chiosis | Conflict of Interest | Samus Therapeutics | 2013 | |
| Thomas Reiner | Conflict of Interest | Summit Biomedical Imaging, LLC | 2018 | |
| Ying-Xian Pan | Conflict of Interest | Sparian Biosciences | 2019 | |
| Gabriela Chiosis | Conflict of Interest | Samus Therapeutics | 2018 | |
| Richard Kolesnick | Conflict of Interest | Ceramedix | 2018 | |
| David Scheinberg | Conflict of Interest | Eureka Therapeutics | 2018 | |
| David Scheinberg | Conflict of Interest | Eureka Therapeutics | 2018 | |
| Edgar Jaimes | Conflict of Interest | Goldilocks Therapeutics | 2018 | |
| Charles Sawyers | Conflict of Interest | ORIC Pharmaceuticals | 2018 | |
| Michelle Bradbury | Conflict of Interest | Elucida Oncology, Inc. | 2017 | |
| Michelle Bradbury | Conflict of Interest | Claymore Technologies, Inc. | 2015 | |
| Ulrish Wiesner | Conflict of Interest | Elucida Oncology, Inc. | 2017 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.